Literature DB >> 27407831

Unstable or High Risk Plaque: How Do We Approach It?

A B Mehta1, Sameer Shah2.   

Abstract

Keywords:  Acute coronary syndrome; High risk plaque; Unstable plaque

Year:  2011        PMID： 27407831      PMCID： PMC4923293          DOI： 10.1016/S0377-1237(06)80141-3

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN： 0377-1237


× No keyword cloud information.
  38 in total

1.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

2.  Detection and characterization of vascular lesions by intravascular ultrasound: an in vitro study correlated with histology.

Authors:  C Di Mario; S H The; S Madretsma; R J van Suylen; R A Wilson; N Bom; P W Serruys; E J Gussenhoven; J R Roelandt
Journal:  J Am Soc Echocardiogr       Date:  1992 Mar-Apr       Impact factor: 5.251

3.  Assessing atherosclerotic plaque morphology: comparison of optical coherence tomography and high frequency intravascular ultrasound.

Authors:  M E Brezinski; G J Tearney; N J Weissman; S A Boppart; B E Bouma; M R Hee; A E Weyman; E A Swanson; J F Southern; J G Fujimoto
Journal:  Heart       Date:  1997-05       Impact factor: 5.994

4.  Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation (IMPRESS Study).

Authors:  Francesco Versaci; Achille Gaspardone; Fabrizio Tomai; Flavio Ribichini; Paolo Russo; Igino Proietti; Anna Silvia Ghini; Valeria Ferrero; Luigi Chiariello; Pier Agostino Gioffrè; Francesco Romeo; Filippo Crea
Journal:  J Am Coll Cardiol       Date:  2002-12-04       Impact factor: 24.094

Review 5.  Frequency of sudden cardiac death and profiles of risk.

Authors:  R J Myerburg; A Interian; R M Mitrani; K M Kessler; A Castellanos
Journal:  Am J Cardiol       Date:  1997-09-11       Impact factor: 2.778

6.  Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease.

Authors:  M Schartl; W Bocksch; D H Koschyk; W Voelker; K R Karsch; J Kreuzer; D Hausmann; S Beckmann; M Gross
Journal:  Circulation       Date:  2001-07-24       Impact factor: 29.690

Review 7.  Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier.

Authors:  J E Muller; G S Abela; R W Nesto; G H Tofler
Journal:  J Am Coll Cardiol       Date:  1994-03-01       Impact factor: 24.094

8.  Clinical and angiographic outcome of patients with mild coronary lesions treated with balloon angioplasty or coronary stenting. Implications for mechanical plaque sealing.

Authors:  N Mercado; W Maier; E Boersma; C Bucher; V de Valk; W W O'Neill; B J Gersh; B Meier; P W Serruys; W Wijns
Journal:  Eur Heart J       Date:  2003-03       Impact factor: 29.983

9.  Coronary angioscopy in patients with unstable angina pectoris.

Authors:  C T Sherman; F Litvack; W Grundfest; M Lee; A Hickey; A Chaux; R Kass; C Blanche; J Matloff; L Morgenstern
Journal:  N Engl J Med       Date:  1986-10-09       Impact factor: 91.245

10.  Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture.

Authors:  P K Shah; E Falk; J J Badimon; A Fernandez-Ortiz; A Mailhac; G Villareal-Levy; J T Fallon; J Regnstrom; V Fuster
Journal:  Circulation       Date:  1995-09-15       Impact factor: 29.690
View more
  1 in total

1.  A Nano-Emulsion Platform Functionalized with a Fully Human scFv-Fc Antibody for Atheroma Targeting: Towards a Theranostic Approach to Atherosclerosis.

Authors:  Samuel Bonnet; Geoffrey Prévot; Stéphane Mornet; Marie-Josée Jacobin-Valat; Yannick Mousli; Audrey Hemadou; Mathieu Duttine; Aurélien Trotier; Stéphane Sanchez; Martine Duonor-Cérutti; Sylvie Crauste-Manciet; Gisèle Clofent-Sanchez
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.